Top compounds associated with response to CBL


Feature Type Standardized
Nominal ANOVA
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.097 0.002
mRNA linifanib GDSC1000 pan-cancer AAC 0.11 0.003
mRNA NSC-207895 GDSC1000 pan-cancer AAC 0.11 0.003
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.096 0.003
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA niclosamide CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.11 0.003
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.1 0.003
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV